JP4435510B2 - High salinity nori treatment liquid and nori treatment method - Google Patents
High salinity nori treatment liquid and nori treatment method Download PDFInfo
- Publication number
- JP4435510B2 JP4435510B2 JP2003196077A JP2003196077A JP4435510B2 JP 4435510 B2 JP4435510 B2 JP 4435510B2 JP 2003196077 A JP2003196077 A JP 2003196077A JP 2003196077 A JP2003196077 A JP 2003196077A JP 4435510 B2 JP4435510 B2 JP 4435510B2
- Authority
- JP
- Japan
- Prior art keywords
- acid
- salt
- sodium
- potassium
- sulfate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000011282 treatment Methods 0.000 title claims description 99
- 239000007788 liquid Substances 0.000 title claims description 42
- 238000000034 method Methods 0.000 title claims description 10
- 235000002639 sodium chloride Nutrition 0.000 claims description 96
- 150000003839 salts Chemical class 0.000 claims description 57
- 241000206607 Porphyra umbilicalis Species 0.000 claims description 50
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 32
- 241001474374 Blennius Species 0.000 claims description 31
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 27
- -1 organic acid salt Chemical class 0.000 claims description 23
- 239000013535 sea water Substances 0.000 claims description 23
- 239000002253 acid Substances 0.000 claims description 22
- 229910017053 inorganic salt Inorganic materials 0.000 claims description 22
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 21
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 18
- 235000001014 amino acid Nutrition 0.000 claims description 17
- 230000005484 gravity Effects 0.000 claims description 16
- 239000011780 sodium chloride Substances 0.000 claims description 16
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims description 12
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 12
- 150000001413 amino acids Chemical class 0.000 claims description 12
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims description 10
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 10
- 235000015165 citric acid Nutrition 0.000 claims description 9
- 239000004310 lactic acid Substances 0.000 claims description 9
- 235000014655 lactic acid Nutrition 0.000 claims description 9
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 8
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 8
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 8
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 8
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 8
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 8
- 239000001630 malic acid Substances 0.000 claims description 8
- 235000011090 malic acid Nutrition 0.000 claims description 8
- 150000007524 organic acids Chemical class 0.000 claims description 8
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 8
- 239000011975 tartaric acid Substances 0.000 claims description 8
- 235000002906 tartaric acid Nutrition 0.000 claims description 8
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 8
- 235000011054 acetic acid Nutrition 0.000 claims description 7
- 239000004471 Glycine Substances 0.000 claims description 6
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 6
- 150000003863 ammonium salts Chemical class 0.000 claims description 6
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims description 6
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims description 6
- 235000011130 ammonium sulphate Nutrition 0.000 claims description 6
- ZCCIPPOKBCJFDN-UHFFFAOYSA-N calcium nitrate Chemical compound [Ca+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ZCCIPPOKBCJFDN-UHFFFAOYSA-N 0.000 claims description 6
- 159000000007 calcium salts Chemical class 0.000 claims description 6
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims description 6
- 239000001530 fumaric acid Substances 0.000 claims description 6
- 235000011087 fumaric acid Nutrition 0.000 claims description 6
- YIXJRHPUWRPCBB-UHFFFAOYSA-N magnesium nitrate Chemical compound [Mg+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O YIXJRHPUWRPCBB-UHFFFAOYSA-N 0.000 claims description 6
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 claims description 6
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 claims description 6
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 claims description 6
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 5
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 5
- 235000004279 alanine Nutrition 0.000 claims description 5
- 235000019270 ammonium chloride Nutrition 0.000 claims description 5
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 5
- 235000011147 magnesium chloride Nutrition 0.000 claims description 5
- 235000005985 organic acids Nutrition 0.000 claims description 5
- 159000000000 sodium salts Chemical class 0.000 claims description 5
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 claims description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 4
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 4
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 4
- 239000001099 ammonium carbonate Substances 0.000 claims description 4
- 235000012501 ammonium carbonate Nutrition 0.000 claims description 4
- 235000003704 aspartic acid Nutrition 0.000 claims description 4
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 4
- 235000013922 glutamic acid Nutrition 0.000 claims description 4
- 239000004220 glutamic acid Substances 0.000 claims description 4
- 159000000003 magnesium salts Chemical class 0.000 claims description 4
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 4
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 4
- GRLPQNLYRHEGIJ-UHFFFAOYSA-J potassium aluminium sulfate Chemical compound [Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRLPQNLYRHEGIJ-UHFFFAOYSA-J 0.000 claims description 4
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 claims description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 4
- 235000011181 potassium carbonates Nutrition 0.000 claims description 4
- 239000011734 sodium Substances 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 4
- 235000017550 sodium carbonate Nutrition 0.000 claims description 4
- 239000001509 sodium citrate Substances 0.000 claims description 4
- 229910052938 sodium sulfate Inorganic materials 0.000 claims description 4
- 235000011152 sodium sulphate Nutrition 0.000 claims description 4
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 claims description 4
- 229940038773 trisodium citrate Drugs 0.000 claims description 4
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 claims description 3
- HSEYYGFJBLWFGD-UHFFFAOYSA-N 4-methylsulfanyl-2-[(2-methylsulfanylpyridine-3-carbonyl)amino]butanoic acid Chemical compound CSCCC(C(O)=O)NC(=O)C1=CC=CN=C1SC HSEYYGFJBLWFGD-UHFFFAOYSA-N 0.000 claims description 3
- 239000004254 Ammonium phosphate Substances 0.000 claims description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 3
- 229910000148 ammonium phosphate Inorganic materials 0.000 claims description 3
- 235000019289 ammonium phosphates Nutrition 0.000 claims description 3
- 239000001110 calcium chloride Substances 0.000 claims description 3
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 3
- 235000011148 calcium chloride Nutrition 0.000 claims description 3
- 239000001506 calcium phosphate Substances 0.000 claims description 3
- 229910000389 calcium phosphate Inorganic materials 0.000 claims description 3
- 235000011010 calcium phosphates Nutrition 0.000 claims description 3
- 235000011132 calcium sulphate Nutrition 0.000 claims description 3
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 claims description 3
- FBAFATDZDUQKNH-UHFFFAOYSA-M iron chloride Chemical compound [Cl-].[Fe] FBAFATDZDUQKNH-UHFFFAOYSA-M 0.000 claims description 3
- 229910000358 iron sulfate Inorganic materials 0.000 claims description 3
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 claims description 3
- 239000011777 magnesium Substances 0.000 claims description 3
- 229910052749 magnesium Inorganic materials 0.000 claims description 3
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 claims description 3
- 239000001095 magnesium carbonate Substances 0.000 claims description 3
- 229910000021 magnesium carbonate Inorganic materials 0.000 claims description 3
- 235000014380 magnesium carbonate Nutrition 0.000 claims description 3
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 claims description 3
- 239000004137 magnesium phosphate Substances 0.000 claims description 3
- 229910000157 magnesium phosphate Inorganic materials 0.000 claims description 3
- 229960002261 magnesium phosphate Drugs 0.000 claims description 3
- 235000010994 magnesium phosphates Nutrition 0.000 claims description 3
- 229910052700 potassium Inorganic materials 0.000 claims description 3
- 239000011591 potassium Substances 0.000 claims description 3
- 239000001103 potassium chloride Substances 0.000 claims description 3
- 235000011164 potassium chloride Nutrition 0.000 claims description 3
- 239000004323 potassium nitrate Substances 0.000 claims description 3
- 235000010333 potassium nitrate Nutrition 0.000 claims description 3
- 229910000160 potassium phosphate Inorganic materials 0.000 claims description 3
- 235000011009 potassium phosphates Nutrition 0.000 claims description 3
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 claims description 3
- 229910052939 potassium sulfate Inorganic materials 0.000 claims description 3
- 235000011151 potassium sulphates Nutrition 0.000 claims description 3
- 239000004317 sodium nitrate Substances 0.000 claims description 3
- 235000010344 sodium nitrate Nutrition 0.000 claims description 3
- 239000001488 sodium phosphate Substances 0.000 claims description 3
- 229910000162 sodium phosphate Inorganic materials 0.000 claims description 3
- 235000011008 sodium phosphates Nutrition 0.000 claims description 3
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 3
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims description 3
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 2
- 239000000243 solution Substances 0.000 description 45
- 229940024606 amino acid Drugs 0.000 description 14
- 239000003795 chemical substances by application Substances 0.000 description 10
- 241000195493 Cryptophyta Species 0.000 description 9
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 8
- 238000010306 acid treatment Methods 0.000 description 7
- 238000007865 diluting Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 6
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 6
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 6
- 239000012895 dilution Substances 0.000 description 6
- 238000010790 dilution Methods 0.000 description 6
- 230000007423 decrease Effects 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 229960003767 alanine Drugs 0.000 description 4
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 239000000174 gluconic acid Substances 0.000 description 3
- 235000012208 gluconic acid Nutrition 0.000 description 3
- 150000007522 mineralic acids Chemical class 0.000 description 3
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 241000206672 Gelidium Species 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- 229940103272 aluminum potassium sulfate Drugs 0.000 description 2
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- LDHQCZJRKDOVOX-NSCUHMNNSA-N crotonic acid Chemical compound C\C=C\C(O)=O LDHQCZJRKDOVOX-NSCUHMNNSA-N 0.000 description 2
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
- 239000011976 maleic acid Substances 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 235000013923 monosodium glutamate Nutrition 0.000 description 2
- 235000006408 oxalic acid Nutrition 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 235000019260 propionic acid Nutrition 0.000 description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 2
- 229940073490 sodium glutamate Drugs 0.000 description 2
- LDHQCZJRKDOVOX-UHFFFAOYSA-N trans-crotonic acid Natural products CC=CC(O)=O LDHQCZJRKDOVOX-UHFFFAOYSA-N 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- 229960004295 valine Drugs 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- UEZVMMHDMIWARA-UHFFFAOYSA-N Metaphosphoric acid Chemical compound OP(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- LCQXXBOSCBRNNT-UHFFFAOYSA-K ammonium aluminium sulfate Chemical compound [NH4+].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O LCQXXBOSCBRNNT-UHFFFAOYSA-K 0.000 description 1
- 238000009360 aquaculture Methods 0.000 description 1
- 244000144974 aquaculture Species 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- FYHXNYLLNIKZMR-UHFFFAOYSA-N calcium;carbonic acid Chemical compound [Ca].OC(O)=O FYHXNYLLNIKZMR-UHFFFAOYSA-N 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 238000011284 combination treatment Methods 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- WDRWZVWLVBXVOI-QTNFYWBSSA-L dipotassium;(2s)-2-aminopentanedioate Chemical compound [K+].[K+].[O-]C(=O)[C@@H](N)CCC([O-])=O WDRWZVWLVBXVOI-QTNFYWBSSA-L 0.000 description 1
- MSJMDZAOKORVFC-SEPHDYHBSA-L disodium fumarate Chemical compound [Na+].[Na+].[O-]C(=O)\C=C\C([O-])=O MSJMDZAOKORVFC-SEPHDYHBSA-L 0.000 description 1
- 238000005553 drilling Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 229940049906 glutamate Drugs 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 159000000014 iron salts Chemical class 0.000 description 1
- 235000013918 magnesium diglutamate Nutrition 0.000 description 1
- 229940063886 magnesium glutamate Drugs 0.000 description 1
- MYUGVHJLXONYNC-QHTZZOMLSA-L magnesium;(2s)-2-amino-5-hydroxy-5-oxopentanoate Chemical compound [Mg+2].[O-]C(=O)[C@@H](N)CCC(O)=O.[O-]C(=O)[C@@H](N)CCC(O)=O MYUGVHJLXONYNC-QHTZZOMLSA-L 0.000 description 1
- 229960004452 methionine Drugs 0.000 description 1
- 235000013919 monopotassium glutamate Nutrition 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 239000011833 salt mixture Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 235000015424 sodium Nutrition 0.000 description 1
- WTWSHHITWMVLBX-DKWTVANSSA-M sodium;(2s)-2-aminobutanedioate;hydron Chemical compound [Na+].[O-]C(=O)[C@@H](N)CC(O)=O WTWSHHITWMVLBX-DKWTVANSSA-M 0.000 description 1
- 229940026510 theanine Drugs 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Cultivation Of Seaweed (AREA)
- Edible Seaweed (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Description
【0001】
【発明の属する技術分野】
本発明は高塩分海苔用処理液及び海苔処理方法に関し、より詳しくは、海苔養殖における雑藻や病害を駆除又は予防するために使用される高塩分含有の海苔用処理液、並びにこの海苔用処理液を使用した海苔処理方法に関する。
本発明の目的は、酸処理液に添加しても酸処理液のpHを殆ど変動させることがない高塩分処理用配合塩を含有することにより、人体および環境へ悪影響をおよぼすことなく、短時間で効率よく雑藻や病害の駆除、予防処理をすることができる海苔用処理液及び海苔処理方法を提供することにある。
【0002】
【従来の技術】
海苔養殖においては、海苔養殖における雑藻であるアオノリ、ケイソウなどや、海苔養殖における病害である赤腐れ病、白腐れ病などを予防、駆除するために海苔用処理液が使用される。
海苔用処理液には、一般的に、グリコール酸、乳酸、酒石酸、リンゴ酸、クエン酸などの有機酸が有効成分として配合され、pHが1.0〜5.0程度に調整されている。このような海苔用処理液に、海苔又は海苔が付着した養殖具を浸漬することにより、雑藻や海苔の病害の駆除又は予防が行われる。
【0003】
海苔処理において、いわゆるもぐり船と呼ばれる海苔処理の専用船が使用されている地域が存在する。もぐり船とは海苔網の下に船を潜らせて海苔用処理液を海苔網の下に素通ししながら処理をする海苔処理用の専用船である。
もぐり船を使用した海苔処理では、海苔網が海苔用処理液に浸漬している時間は、30〜120秒と極めて短く、雑藻や病害を短時間で効率よく駆除することができる海苔用処理液が求められている。
【0004】
本出願人は、短時間で雑藻や病害の駆除、予防処理をすることを可能とした海苔の処理方法及び海苔用処理液として、海水と無機塩類と酸とを含み、比重を1.03〜1.20に調整し、pHを0.5〜5.0に調整した海苔用処理液を提案している(特許文献1参照)。
【0005】
【特許文献1】
特開平9−201180号公報
【0006】
【発明が解決しようとする課題】
上記した海苔用処理液を使用して海苔処理を行うには、海水に酸処理剤と無機塩類を溶解して、pHと比重を調整して高塩分の海苔用処理液を調製する。この海苔用処理液に海苔網を浸漬することにより、海苔処理を行うことができる。通常の場合、塩化ナトリウムが用いられ、その添加量は処理液に対して1〜5重量%程度であり、処理液のpHは塩化ナトリウムを添加しない場合に比べて約0.03〜0.2程度低下し、処理液の比重は塩化ナトリウムを添加しない場合に比べて0.007〜0.035程度上昇する。
この海苔用処理液は、例えば、赤腐れ菌を30秒〜120秒以内の処理時間で80〜100%駆除することができ、短時間処理が求められるもぐり船処理に適した海苔用処理液である。
【0007】
もぐり船処理では船内に設置したpHメーターに処理液のpH値を設定する。処理中に処理液のpHが設定値よりも上昇すると、自動的(或いは人為的)に酸が供給されて、pHが設定値に達すると酸供給が止まる仕組みになっている。
無機塩類を含有する処理液の場合、塩の溶解量によって処理液のpHが変動する。このために、処理液のpHから処理液の酸濃度を把握することが困難となり、予定した酸濃度と実際の処理液の酸濃度との間のずれが大きくなり、効きむらが生じやすくなるといった問題が存在した。
【0008】
本発明は上記課題を解決するためになされたものであり、酸処理液に添加しても酸処理液のpHを殆ど変動させることがない高塩分処理用配合塩を含有することにより、人体および環境へ悪影響をおよぼすことなく、短時間で効率よく雑藻や病害の駆除、予防処理をすることができ、しかも、処理液のpHから容易に酸濃度を把握することができ、効きむらなどが生じにくい海苔用処理液及び海苔処理方法を提供することにある。
【0009】
【課題を解決するための手段】
請求項1に係る発明は、塩化ナトリウム、塩化カリウム、塩化マグネシウム、塩化アンモニウム、塩化カルシウム、塩化鉄、硝酸ナトリウム、硝酸カリウム、硝酸マグネシウム、硝酸アンモニウム、硝酸カルシウム、硫酸アルミニウムアンモニウム、硫酸アルミニウムカリウムからなる群から選択される一種以上の第一の無機塩類、(a)から選択される有機酸のナトリウム塩、カリウム塩、マグネシウム塩、カルシウム塩、アンモニウム塩から選択される一種又は二種以上の有機酸塩、海水及び酸を含有し、比重が1.03〜1.20に調整され、pHが0.5〜5.0に調整されてなる海苔用処理液に関する。
(a)リンゴ酸、クエン酸、酢酸、乳酸、酒石酸、フマル酸から選ばれる一種又は二種以上の有機酸
【0010】
請求項2に係る発明は、第一の無機塩類である塩化ナトリウム、有機酸塩であるクエン酸三ナトリウム、海水及び酸を含有し、比重が1.03〜1.20に調整され、pHが0.5〜5.0に調整されてなる海苔用処理液に関する。
【0011】
請求項3に係る発明は、以下の(b)又は(c)のうちの一種又は二種以上を含むことを特徴とする請求項1又は2に記載の海苔用処理液に関する。
(b)グリシン、アラニン、アスパラギン酸、グルタミン酸から選ばれる一種又は二種以上のアミノ酸、及び/又は該アミノ酸のナトリウム塩、カリウム塩、マグネシウム塩、カルシウム塩から選ばれる一種又は二種以上のアミノ酸塩
(c)硫酸ナトリウム、硫酸カリウム、硫酸マグネシウム、硫酸アンモニウム、硫酸カルシウム、硫酸鉄、リン酸ナトリウム、リン酸カリウム、リン酸マグネシウム、リン酸アンモニウム、リン酸カルシウム、炭酸ナトリウム、炭酸カリウム、炭酸マグネシウム、炭酸アンモニウム、炭酸カルシウムからなる群から選択される一種以上の第二の無機塩類。
【0012】
請求項4に係る発明は、前記酸が、リンゴ酸、クエン酸、酢酸、乳酸、酒石酸、フマル酸からなる群から選択される一種以上であることを特徴とする請求項1乃至3のいずれかに記載の海苔用処理液に関する。
請求項5に係る発明は、請求項1乃至4のいずれかに記載の海苔用処理液に、海苔又は海苔が付着した養殖具を浸漬することを特徴とする海苔処理方法に関する。
【0013】
【発明の実施の形態】
以下、高塩分処理用配合塩、及び本発明に係る海苔用処理液及び海苔処理方法について詳述する。
高塩分処理用配合塩は、第一の無機塩類を含有する。
【0014】
第一の無機塩類としては、塩化ナトリウム、塩化カリウム、塩化マグネシウム、塩化アンモニウム、塩化カルシウム、硝酸ナトリウム、硝酸カリウム、硝酸マグネシウム、硝酸アンモニウム、硝酸カルシウム、硫酸アルミニウムアンモニウム、硫酸アルミニウムカリウム、塩化鉄等を例示することができ、これらのうちから選ばれた一種または二種以上を用いることができる。
特に、第一の無機塩類として、塩化ナトリウム、塩化マグネシウム、塩化アンモニウム、硫酸アルミニウムアンモニウム、硫酸アルミニウムカリウムからなる群から選択される一種以上を用いることが好ましく、塩化ナトリウム、塩化マグネシウム、塩化アンモニウムからなる群から選択される一種以上を用いることがより好ましい。
【0015】
高塩分処理用配合塩には上記した第一の無機塩類に加えて、(a) 有機酸塩類、(b)アミノ酸及び/ 又はアミノ酸塩、(c)前記第一の無機塩類を除く第二の無機塩類、の(a)〜(c)のうちの一又は二以上を含有する。
【0016】
(a)有機酸塩類としては、有機酸のナトリウム塩、カリウム塩、マグネシウム塩、カルシウム塩、アンモニウム塩などを例示することができ、具体的には、リンゴ酸、クエン酸、酢酸、乳酸、フマル酸、グルコン酸、マレイン酸、マロン酸、ギ酸、酒石酸、アクリル酸、クロトン酸、シュウ酸、コハク酸、グルタル酸、プロピオン酸等の有機酸のナトリウム塩、カリウム塩、マグネシウム塩、カルシウム塩、アンモニウム塩等を例示することができる。これらのうちの一種又は二種以上を含有することができる。
特に、有機酸塩類として、リンゴ酸、クエン酸、酢酸、グルコン酸、乳酸、酒石酸、フマル酸のナトリウム塩、カリウム塩を用いることが好ましい。
【0017】
有機酸塩類を配合する場合、その含有量は特に限定されないが、高塩分処理用配合塩中の第一の無機塩類の含有量の0.01〜20重量部、好ましくは0.05〜10重量部、より好ましくは0.1〜5重量部とされる。0.01重量部未満の場合及び20重量部を超える場合のいずれも、高塩分処理用配合塩から調製される処理液のpH変動を抑制する効果が低い。
【0018】
(b)アミノ酸としては、グリシン、アラニン、バリン、ロイシン、イソロイシン、フェニルアラニン、トリプトファン、プロリン、メチオニン、セリン、スレオニン、システイン、チロシン、アスパラギン、グルタミン、ヒスチジン、リシン、アルギニン、アスパラギン酸、グルタミン酸等を例示することができ、これらのうちの一種又は二種以上を用いることができる。
また、前記したアミノ酸の塩、具体的にはアミノ酸のナトリウム塩、カリウム塩、マグネシウム塩、カルシウム塩、アンモニウム塩も好適に使用することができる。
特に、グリシン、アスパラギン酸ナトリウム、アラニン、グルタミン酸、グルタミン酸ナトリウム、グルタミン酸カリウム、グルタミン酸カルシウム、グルタミン酸マグネシウム、テアニン、バリン、メチオニン、イソロイシンのうちの一種又は二種以上を用いることが好ましく、グリシン、アスパラギン酸ナトリウム、アラニン、グルタミン酸ナトリウムのうちの一種又は二種以上を用いることがより好ましい。
【0019】
アミノ酸又はアミノ酸塩を配合する場合、その含有量は特に限定されないが、高塩分処理用配合塩中の第一の無機塩類の配合量の、0.01〜30重量部、好ましくは0.05〜20重量部、より好ましくは0.1 〜10重量部とされる。
0.01重量部未満の場合及び20重量部を超える場合のいずれも、高塩分処理用配合塩から調製される処理液のpH変動を抑制する効果が低い。
【0020】
(c)前記第一の無機塩類を除く第二の無機塩類が配合される。第二の無機塩類は、前記第一の無機塩類以外の無機塩類であれば特に限定されず、アルカリ金属、アルカリ土類金属、アンモニウム塩類、鉄塩類等を例示することができる。
具体的には、硫酸ナトリウム、硫酸カリウム、硫酸マグネシウム、硫酸アンモニウム、硫酸カルシウム、リン酸ナトリウム、リン酸カリウム、リン酸マグネシウム、リン酸アンモニウム、リン酸カルシウム、炭酸ナトリウム、炭酸カリウム、炭酸マグネシウム、炭酸アンモニウム、炭酸カルシウム、硫酸鉄等を例示することができ、これらのうちから選ばれた一種または二種以上を用いることができる。
特に、第二の無機塩類として、硫酸アンモニウム、硫酸ナトリウム、硫酸マグネシウム、炭酸ナトリウム、炭酸カリウム、炭酸アンモニウムからなる群から選択される一種以上を用いることが好ましい。
【0021】
第二の無機塩類を配合する場合、その含有量は特に限定されないが、高塩分処理用配合塩中の第一の無機塩類の配合量の、0.1〜50重量部、好ましくは0.5〜30重量部、より好ましくは1〜20重量部とされる。0.5重量部未満の場合及び30重量部を超える場合のいずれも、高塩分処理用配合塩から調製される処理液のpH変動を抑制する効果が低い。
【0022】
本発明では、上述した(a)有機酸塩類、(b)アミノ酸及び/又はアミノ酸塩、(c)前記第一の無機塩類のいずれも好適に使用することができるが、特に(a)有機酸塩類又は(c)前記第一の無機塩類を用いることが好ましい。
【0023】
高塩分処理用配合塩では、上記した各成分の海水への溶解性や分散性を高めて、取扱い易くすることを目的として、上記した各成分を水に溶解して高塩分処理用液とすることもできる。
用いられる水の量は特に限定されないが、上記した各成分の合計量1kgを1〜9kg、好ましくは1.5〜4kgの水に溶解すればよい。水の使用量が1kg未満の場合、各成分を十分に溶解することが困難となる場合がある。水の使用量が9kgを超える場合、高塩分処理用配合塩の容量が大きくなり、保管や取扱いの面で劣る場合がある。
【0024】
以上説明した高塩分処理用配合塩を酸と共に海水に溶解又は海水で希釈することにより、
本発明に係る海苔用処理液を調製することができる。
酸としては、無機酸、カルボン酸、有機リン酸を用いることができる。
無機酸としては、硫酸、硝酸、塩酸、リン酸などを例示することができ、これらのうちの一種または二種以上を用いることができる。
カルボン酸としては、リンゴ酸、クエン酸、酢酸、乳酸、フマル酸、グルコン酸、マレイン酸、マロン酸、蟻酸、酒石酸、アクリル酸、クロトン酸、シュウ酸、コハク酸、グルタル酸、プロピオン酸等を例示することができ、これらのうちの一種または二種以上を用いることができる。
有機リン酸としては、フィチン酸、メタリン酸、ポリリン酸等を例示することができ、これらのうちの一種または二種以上を用いることができる
【0025】
本発明に係る海苔用処理液を調製する際に使用される海水としては、外洋、内海を問わず、海苔を養殖することができる海水が使用される。海水の性質は瀬戸内海、有明海、東京湾等の場所によっては異なるが、通常の場合、海水の比重は1.018〜1.025の値の範囲に含まれている。本発明では、海水に無機塩類と酸とを加えて海苔用処理液が調製される。
【0026】
本発明に係る海苔用処理液は、比重を1.03〜1.20、好ましくは比重を1.03〜1.13に調整される。比重が1.03未満であると、従来の処理液と比較して、海苔以外の藻類や赤腐れ病、白腐れ病などの病害の防除効果が同程度である。比重が1.20を超える場合、比重が高くなりすぎて正常な海苔を傷める危険性が増すことがある。
【0027】
本発明に係る海苔用処理液は、pHを0.5〜5.0、好ましくは1.5〜3.0に調整される。処理液のpHが0.5未満であると、正常な海苔を傷める危険性が増すとともに、環境に与える影響も大きくなる。処理液のpHが5.0を超えると、海苔以外の藻類や赤腐れ病や白腐れ病などの病害を駆除する効果が低下する場合がある。
【0028】
上述した高塩分処理用配合塩は、前記比重又は前記pHの範囲内となるように海水に添加すれば、海水に添加される高塩分処理用配合塩の量は特に限定されないが、通常の場合、海水100リットルに対して、水を除く高塩分処理用配合塩の各成分を1〜20kg、好ましくは3〜10kg程度添加する。
【0029】
本発明に係る海苔用処理液中の酸及び第一の無機塩類の含有量は特に限定されないが、酸及び第一の無機塩類の含有量は、概ね以下のようになる。
酸の含有量は、処理液の比重又はpHを前述の範囲内となるように調整することができる量であれば適当量添加することができる。無機酸を添加する場合、好ましくは0.005〜5.0重量%とされる。有機酸を添加する場合、好ましくは0.01〜5.0重量%とされる。
第一の無機塩類の含有量は、処理液の比重又はpHを前述の範囲内となるように調整することができる量であれば適当量添加することができ、好ましくは0.25重量%〜飽和量とされる。
【0030】
本発明に係る海苔用処理液を使用して海苔処理を行うには、本発明に係る海苔用処理液に、海苔または海苔が付着した養殖具を所要時間浸漬すればよい。
具体的には、本発明に係る海苔用処理液を船内の処理液槽等の容器内に入れ、処理液中に海苔または海苔が付着した養殖具を浸漬すればよい。またもぐり船等のように、海苔の養殖網の下に船を潜らせて、処理液を網の下に素通ししながら処理をすることもできる。
海苔または海苔が付着した養殖具を処理液中に浸漬する時間は特に限定されないが、10秒〜10分以内で処理を終了することができる。
【0031】
【実施例】
以下、本発明を実施例に基づき説明するが、本発明はこれらの実施例に何ら限定されるものではない。
以下の組成に基づき海苔用処理剤を調製した。
<海苔用処理剤の組成>
(80%)乳酸 50
(75%)リン酸 12
(35%)塩酸 4
クエン酸 10
脱イオン水 24
合計 100重量%
【0032】
上記海苔用処理剤を表1に記載の希釈倍率となるように海水で希釈して調製した海苔用処理液に、塩化ナトリウムを0〜13重量%添加した。この処理液のpHを測定した。結果を表1に記載する。
【表1】
【0033】
上記海苔用処理剤を表2に記載の希釈倍率となるように海水で希釈して調製した海苔用処理液に、塩化ナトリウム(98.9重量%)及びクエン酸三ナトリウム(結晶)(1.1重量%)からなる配合塩を0〜13重量%添加した。この処理液のpHを測定した。結果を表2に記載する。
【表2】
【0034】
上記海苔用処理剤を表3に記載の希釈倍率となるように海水で希釈して調製した海苔用処理液に、塩化ナトリウム(99.24重量%)及びクエン酸三ナトリウム(結晶)(0.76重量%)からなる配合塩を0〜13重量%添加した。この処理液のpHを測定した。結果を表3に記載する。
【表3】
【0035】
上記海苔用処理剤を表4に記載の希釈倍率となるように海水で希釈して調製した海苔用処理液に、塩化ナトリウム(77重量%)及び硫酸アンモニウム(23重量%)からなる配合塩を0〜13重量%添加した。この処理液のpHを測定した。結果を表4に記載する。
【表4】
【0036】
上記海苔用処理剤を表5に記載の希釈倍率となるように海水で希釈して調製した海苔用処理液に、塩化ナトリウム(98.55重量%)及びグリシン(1.45重量%)からなる配合塩を0〜13重量%添加した。この処理液のpHを測定した。結果を表5に記載する。
【表5】
【0037】
上記海苔用処理剤を表6に記載の希釈倍率となるように海水で希釈して調製した海苔用処理液に、塩化ナトリウム(88重量%)、硫酸アンモニウム(11.45重量%)及びクエン酸三ナトリウム(結晶)(0.6重量%)からなる配合塩を0〜13重量%添加した。この処理液のpHを測定した。結果を表6に記載する。
【表6】
【0038】
表1に示される通り、海苔用処理剤を海水で希釈した海苔用処理液に無機塩類の一種類を添加した場合は、無機塩類の添加量が増加するにつれ、海苔用処理液のpHが低下した。
一方、表2及び3に示されるように、無機塩類と有機酸塩とを組み合わせて添加した場合、無機塩類と有機酸塩の添加量が増加しても処理液のpHは低下せず、ほぼ一定の値を示した。
表4に示されるように、二種類の無機塩類を組み合わせて添加した場合、無機塩類の添加量が増加しても処理液のpHは低下せず、ほぼ一定の値を示した。
表5に示されるように、無機塩類とアミノ酸とを組み合わせて添加した場合、無機塩類とアミノ酸の添加量が増加しても処理液のpHは低下せず、ほぼ一定の値を示した。
表6に示されるように、二種類の無機塩類と有機酸塩とを組み合わせて添加した場合、無機塩類と有機酸塩の添加量が増加しても処理液のpHは低下せず、ほぼ一定の値を示した。
【0039】
【発明の効果】
本発明の請求項1乃至4に係る発明によれば、酸処理液への添加量が増減しても酸処理液のpH変動が少ない高塩分処理用配合塩を用いることにより、人体および環境へ悪影響をおよぼすことなく、低コストで、広いpH領域で使用でき、短時間で効率よく雑藻や病害の駆除、予防処理をすることができる高塩分含有の海苔用処理液を提供することができる。また、無機塩類の溶解量によるpH変動が少なく、処理液のpHから容易に酸濃度を把握することができ、効きむらなどが生じにくい海苔用処理液を提供することができる。本発明の請求項5に係る発明によれば、処理液のpHから酸濃度を容易に把握することができ、海苔処理中、酸濃度を一定に維持することが容易であり、効きむらなどが発生することなく海苔を処理することができる海苔処理方法を提供することができる。[0001]
BACKGROUND OF THE INVENTION
The present invention relates to high salinity sea moss treatment liquid and seaweed processing method, and more particularly, seaweed treatment solution of the high salt content that is used for combating or preventing Zatsumo and diseases in sea moss farming, and this The present invention relates to a laver treatment method using a laver treatment solution.
The object of the present invention is to contain a high salt content blending salt that hardly changes the pH of the acid treatment solution even when added to the acid treatment solution, so that the human body and the environment are not adversely affected. It is another object of the present invention to provide a laver treatment solution and a laver treatment method that can efficiently remove and prevent miscellaneous algae and diseases.
[0002]
[Prior art]
In nori culture, a processing solution for nori is used to prevent and control red seaweed, white rot, etc., which are algae in seaweed aquaculture, such as aonori and diatom.
Generally, organic acids such as glycolic acid, lactic acid, tartaric acid, malic acid, and citric acid are blended as active ingredients in the laver treatment solution, and the pH is adjusted to about 1.0 to 5.0. By immersing a seaweed or a culture tool to which the seaweed is attached in such a laver treatment solution, it is possible to eliminate or prevent diseases of miscellaneous algae and seaweed.
[0003]
In laver processing, there is an area where a special ship for laver processing called so-called mooring boat is used. A mooring ship is a dedicated ship for laver treatment that processes the seaweed treatment liquid while passing it under the laver net.
In the laver treatment using a mooring ship, the time that the laver net is immersed in the laver treatment solution is extremely short, 30 to 120 seconds, and the nori treatment that can effectively remove miscellaneous algae and diseases in a short time. Liquid is sought.
[0004]
The present applicant includes seawater, inorganic salts, and acid as a laver treatment method and a laver treatment solution that enables the elimination and prevention treatment of miscellaneous algae and diseases in a short time, and has a specific gravity of 1.03. A seaweed processing solution with a pH adjusted to 0.5 to 5.0 with a pH adjusted to -1.20 is proposed (see Patent Document 1).
[0005]
[Patent Document 1]
JP-A-9-201180 [0006]
[Problems to be solved by the invention]
In order to perform a laver treatment using the above-mentioned laver treatment solution, an acid treatment agent and an inorganic salt are dissolved in seawater, pH and specific gravity are adjusted, and a high salinity laver treatment solution is prepared. A seaweed treatment can be performed by immersing a seaweed net in the seaweed processing solution. In normal cases, sodium chloride is used, and the amount added is about 1 to 5% by weight with respect to the treatment liquid, and the pH of the treatment liquid is about 0.03 to 0.2 compared to the case where sodium chloride is not added. The specific gravity of the treatment liquid is increased by about 0.007 to 0.035 compared to the case where sodium chloride is not added.
This nori treatment liquid is, for example, a nori treatment liquid that can remove red rot fungi by 80 to 100% in a treatment time of 30 seconds to 120 seconds, and is suitable for drilling ship processing that requires short-time treatment. is there.
[0007]
In mogboat processing, the pH value of the processing solution is set in a pH meter installed in the ship. When the pH of the processing solution rises above the set value during processing, the acid is supplied automatically (or artificially), and when the pH reaches the set value, the acid supply is stopped.
In the case of a treatment liquid containing inorganic salts, the pH of the treatment liquid varies depending on the amount of dissolved salt. For this reason, it becomes difficult to grasp the acid concentration of the treatment liquid from the pH of the treatment liquid, and the deviation between the planned acid concentration and the actual acid concentration of the treatment liquid becomes large, and unevenness of the effect is likely to occur. There was a problem.
[0008]
The present invention has been made to solve the above-mentioned problems, and contains a human salt and a high salt content combination salt that hardly changes the pH of the acid treatment solution even when added to the acid treatment solution. Efficient removal and prevention of miscellaneous algae and diseases can be performed in a short time without adversely affecting the environment, and the acid concentration can be easily determined from the pH of the processing solution. An object of the present invention is to provide a laver treatment solution and a laver treatment method that are unlikely to occur.
[0009]
[Means for Solving the Problems]
The invention according to claim 1 is from the group consisting of sodium chloride, potassium chloride, magnesium chloride, ammonium chloride, calcium chloride, iron chloride, sodium nitrate, potassium nitrate, magnesium nitrate, ammonium nitrate, calcium nitrate, aluminum ammonium sulfate, and aluminum potassium sulfate. One or more first inorganic salts selected, a sodium salt of an organic acid selected from (a), a potassium salt, a magnesium salt, a calcium salt, one or two or more organic acid salts selected from ammonium salts; The present invention relates to a seaweed treatment solution containing seawater and an acid, having a specific gravity adjusted to 1.03-1.20 and a pH adjusted to 0.5-5.0 .
(A) One or more organic acids selected from malic acid, citric acid, acetic acid, lactic acid, tartaric acid and fumaric acid
The invention according to claim 2 contains sodium chloride as the first inorganic salt, trisodium citrate as the organic acid salt, seawater and acid, the specific gravity is adjusted to 1.03-1.20, and the pH is The present invention relates to a laver treatment liquid adjusted to 0.5 to 5.0 .
[0011]
The invention according to claim 3 relates to a processing solution for laver according to claim 1 or 2, characterized in that it contains one or more of the following (b) or (c).
(B) One or more amino acids selected from glycine, alanine, aspartic acid, and glutamic acid, and / or one or more amino acid salts selected from sodium, potassium, magnesium, and calcium salts of the amino acid
(C) sodium sulfate, potassium sulfate, magnesium sulfate, ammonium sulfate, calcium sulfate, iron sulfate, sodium phosphate, potassium phosphate, magnesium phosphate, ammonium phosphate, calcium phosphate, sodium carbonate, potassium carbonate, magnesium carbonate, ammonium carbonate, One or more second inorganic salts selected from the group consisting of calcium carbonate.
[0012]
The invention according to claim 4 is characterized in that the acid is one or more selected from the group consisting of malic acid, citric acid, acetic acid, lactic acid, tartaric acid, and fumaric acid. The processing solution for laver described in 1.
The invention according to claim 5 relates to a laver treatment method, wherein a laver or a culture tool to which the laver is adhered is immersed in the laver treatment liquid according to any of claims 1 to 4.
[0013]
DETAILED DESCRIPTION OF THE INVENTION
Hereinafter , the high salt content mixed salt, and the laver treatment liquid and laver treatment method according to the present invention will be described in detail.
The compound salt for high salinity treatment contains the first inorganic salt.
[0014]
Examples of the first inorganic salts include sodium chloride, potassium chloride, magnesium chloride, ammonium chloride, calcium chloride, sodium nitrate, potassium nitrate, magnesium nitrate, ammonium nitrate, calcium nitrate, aluminum ammonium sulfate, aluminum potassium sulfate, and iron chloride. One or two or more selected from these can be used.
In particular, as the first inorganic salts, sodium chloride, magnesium chloride, ammonium chloride, ammonium aluminum sulfate, it is preferable to use one or more kinds selected from the group consisting of potassium aluminum sulfate, sodium chloride, magnesium chloride, ammonium chloride It is more preferable to use one or more selected from the group consisting of:
[0015]
In addition to the above-mentioned first inorganic salt, the high salt treatment combination salt includes (a) an organic acid salt, (b) an amino acid and / or amino acid salt, and (c) a second excluding the first inorganic salt. One or more of (a) to (c) of inorganic salts are contained.
[0016]
(A) Examples of organic acid salts include sodium salts, potassium salts, magnesium salts, calcium salts and ammonium salts of organic acids. Specifically, malic acid, citric acid, acetic acid, lactic acid, fumarate Sodium, potassium, magnesium, calcium, and ammonium salts of organic acids such as acid , gluconic acid, maleic acid, malonic acid, formic acid, tartaric acid, acrylic acid, crotonic acid, oxalic acid, succinic acid, glutaric acid, and propionic acid A salt etc. can be illustrated. One or more of these can be contained.
In particular, as organic acid salts, malic acid, citric acid, acetic acid, gluconic acid, lactic acid, tartaric acid, sodium salts of fumaric acid, it is preferred to use a potassium salt.
[0017]
When the organic acid salt is blended, its content is not particularly limited, but 0.01 to 20 parts by weight of the content of the first inorganic salt in the blended salt for high salinity treatment, preferably 0.05 to 10 parts by weight. Parts, more preferably 0.1 to 5 parts by weight. In both cases of less than 0.01 parts by weight and in excess of 20 parts by weight, the effect of suppressing the pH fluctuation of the treatment liquid prepared from the high salt content combination salt is low.
[0018]
(B) Examples of amino acids include glycine, alanine, valine, leucine, isoleucine, phenylalanine, tryptophan, proline, methionine, serine, threonine, cysteine, tyrosine, asparagine, glutamine, histidine, lysine, arginine, aspartic acid, glutamic acid, etc. One or two or more of these can be used.
Also, salts of the amino acids, can be specifically the sodium salt of an amino acid, potassium salt, magnesium salt, calcium salt, also ammonium salts preferably used.
In particular, glycine, sodium aspartate, alanine, glutamate, sodium glutamate, potassium glutamate, glutamic acid calcium, magnesium glutamate, theanine, valine, methionine, it is used one or two or more of isoleucine Preferably, glycine, aspartic acid It is more preferable to use one or more of sodium, alanine, and sodium glutamate.
[0019]
When the amino acid or amino acid salt is blended, its content is not particularly limited, but is 0.01 to 30 parts by weight, preferably 0.05 to the blending amount of the first inorganic salt in the high salt treatment blending salt. 20 parts by weight, more preferably 0.1 to 10 parts by weight.
In both cases of less than 0.01 parts by weight and in excess of 20 parts by weight, the effect of suppressing the pH fluctuation of the treatment liquid prepared from the high salt content combination salt is low.
[0020]
(C) Second inorganic salts excluding the first inorganic salts are blended. The second inorganic salt is not particularly limited as long as it is an inorganic salt other than the first inorganic salt, and examples thereof include alkali metals, alkaline earth metals, ammonium salts, and iron salts.
Specifically, sodium sulfate, potassium sulfate, magnesium sulfate, ammonium sulfate, calcium sulfate, sodium phosphate, potassium phosphate, magnesium phosphate, ammonium phosphate, calcium phosphate, sodium carbonate, potassium carbonate, magnesium carbonate, ammonium carbonate, carbonic acid Calcium, iron sulfate and the like can be exemplified, and one or two or more selected from these can be used.
In particular, as the second inorganic salts, ammonium sulfate, sodium sulfate, magnesium sulfate, sodium carbonate, potassium carbonate, it is preferable to use one or more selected from the group consisting of ammonium carbonate.
[0021]
When blending the second inorganic salt, the content is not particularly limited, but is 0.1 to 50 parts by weight, preferably 0.5, of the blending amount of the first inorganic salt in the blended salt for high salinity treatment. -30 parts by weight, more preferably 1-20 parts by weight. In both the case of less than 0.5 part by weight and the case of exceeding 30 parts by weight, the effect of suppressing the pH fluctuation of the treatment liquid prepared from the high salt content combination salt is low.
[0022]
In the present invention, any of the above-mentioned (a) organic acid salts, (b) amino acids and / or amino acid salts, and (c) the first inorganic salts can be preferably used. It is preferable to use a salt or (c) the first inorganic salt.
[0023]
In the salt mixture for high salinity treatment, for the purpose of improving the solubility and dispersibility of each component in seawater and making it easy to handle, the above-mentioned components are dissolved in water to obtain a solution for high salt treatment. You can also.
The amount of water used is not particularly limited, but 1 kg of the total amount of each component described above may be dissolved in 1 to 9 kg, preferably 1.5 to 4 kg of water. When the amount of water used is less than 1 kg, it may be difficult to sufficiently dissolve each component. When the usage-amount of water exceeds 9 kg, the capacity | capacitance of the compound salt for high salt processing becomes large, and it may be inferior in terms of storage and handling.
[0024]
By dissolving or diluting the high salt treatment mixed salt described above with seawater in seawater,
The processing solution for laver according to the present invention can be prepared.
As the acid, inorganic acid, carboxylic acid, or organic phosphoric acid can be used.
Examples of inorganic acids include sulfuric acid, nitric acid, hydrochloric acid, phosphoric acid, and the like, and one or more of these can be used.
Carboxylic acids include malic acid, citric acid, acetic acid, lactic acid, fumaric acid , gluconic acid, maleic acid, malonic acid, formic acid, tartaric acid, acrylic acid, crotonic acid, oxalic acid, succinic acid, glutaric acid, propionic acid, etc. Examples can be given, and one or more of these can be used.
Examples of the organic phosphoric acid include phytic acid, metaphosphoric acid, polyphosphoric acid and the like, and one or more of these can be used.
As seawater used when preparing the processing solution for laver according to the present invention, seawater capable of cultivating laver is used regardless of the open sea or the inland sea. The nature of seawater varies depending on places such as the Seto Inland Sea, Ariake Sea, Tokyo Bay, etc., but the specific gravity of seawater is usually included in the range of 1.018 to 1.025. In the present invention, a seaweed treatment solution is prepared by adding inorganic salts and an acid to seawater.
[0026]
The processing solution for laver according to the present invention has a specific gravity of 1.03 to 1.20, preferably a specific gravity of 1.03 to 1.13. When the specific gravity is less than 1.03, the effect of controlling diseases such as algae other than seaweed, red rot, and white rot is comparable to that of conventional treatment solutions. When the specific gravity exceeds 1.20, the specific gravity may become too high, and the risk of damaging normal seaweed may increase.
[0027]
The nori treatment liquid according to the present invention has a pH adjusted to 0.5 to 5.0, preferably 1.5 to 3.0. If the pH of the treatment liquid is less than 0.5, the risk of damaging normal laver increases and the impact on the environment also increases. When the pH of the treatment liquid exceeds 5.0, the effect of eliminating diseases such as algae other than laver, red rot and white rot may be reduced.
[0028]
The amount of the high salt treatment compound salt added to the seawater is not particularly limited as long as the high salt treatment compound salt described above is added to seawater so as to be in the specific gravity or the pH range. In addition, 1 to 20 kg, preferably 3 to 10 kg, of each component of the high salt content mixed salt excluding water is added to 100 liters of seawater.
[0029]
The contents of the acid and the first inorganic salt in the seaweed processing solution according to the present invention are not particularly limited, but the contents of the acid and the first inorganic salt are generally as follows.
The acid content can be added in an appropriate amount as long as the specific gravity or pH of the treatment liquid can be adjusted to be within the above-mentioned range. When adding an inorganic acid, Preferably it is 0.005 to 5.0 weight%. When adding an organic acid, it is preferably 0.01 to 5.0% by weight.
The content of the first inorganic salt can be added in an appropriate amount as long as the specific gravity or pH of the treatment liquid can be adjusted so as to be within the above-mentioned range, preferably from 0.25 wt% to Saturated amount.
[0030]
In order to perform the laver treatment using the laver treatment liquid according to the present invention, the nori or the culture tool to which the laver adheres may be immersed in the laver treatment liquid according to the present invention for a required time.
Specifically, the seaweed processing liquid according to the present invention may be placed in a vessel such as a processing liquid tank in a ship, and the culture tool to which the seaweed or laver adheres may be immersed in the processing liquid. Also, like a moored boat, the ship can be submerged under a nori culture net, and the processing liquid can be processed while passing under the net.
Although the time for immersing the seaweed or the culture tool attached with the seaweed in the treatment liquid is not particularly limited, the treatment can be completed within 10 seconds to 10 minutes.
[0031]
【Example】
EXAMPLES Hereinafter, although this invention is demonstrated based on an Example, this invention is not limited to these Examples at all.
A nori processing agent was prepared based on the following composition.
<Composition of processing agent for seaweed>
(80%) Lactic acid 50
(75%) phosphoric acid 12
(35%) Hydrochloric acid 4
Citric acid 10
Deionized water 24
Total 100% by weight
[0032]
Sodium chloride was added in an amount of 0 to 13% by weight to a seaweed treatment solution prepared by diluting the seaweed treatment agent with seawater so as to achieve the dilution ratio shown in Table 1. The pH of this treatment solution was measured. The results are listed in Table 1.
[Table 1]
[0033]
To the treatment solution for laver prepared by diluting the above-mentioned treatment agent for laver with seawater so as to achieve the dilution ratio shown in Table 2, sodium chloride (98.9 wt%) and trisodium citrate (crystal) (1. 1 to 13% by weight of a mixed salt was added. The pH of this treatment solution was measured. The results are listed in Table 2.
[Table 2]
[0034]
To the treatment solution for laver prepared by diluting the above-mentioned treatment agent for laver with seawater so as to have the dilution ratio shown in Table 3, sodium chloride (99.24% by weight) and trisodium citrate (crystal) (0. 76 wt%) was added in an amount of 0 to 13 wt%. The pH of this treatment solution was measured. The results are listed in Table 3.
[Table 3]
[0035]
To the nori treatment solution prepared by diluting the nori treatment agent with seawater so that the dilution ratio shown in Table 4 is obtained, a mixed salt composed of sodium chloride (77% by weight) and ammonium sulfate (23% by weight) is added. ˜13 wt% added. The pH of this treatment solution was measured. The results are listed in Table 4.
[Table 4]
[0036]
A nori treatment solution prepared by diluting the nori treatment agent with seawater so as to achieve the dilution ratio shown in Table 5 comprises sodium chloride (98.55 wt%) and glycine (1.45 wt%). 0-13 wt% of compounded salt was added. The pH of this treatment solution was measured. The results are listed in Table 5.
[Table 5]
[0037]
To the nori treatment solution prepared by diluting the nori treatment agent with seawater so as to achieve the dilution ratios shown in Table 6, sodium chloride (88 wt%), ammonium sulfate (11.45 wt%) and tricitrate 0 to 13% by weight of a compound salt consisting of sodium (crystal) (0.6% by weight) was added. The pH of this treatment solution was measured. The results are listed in Table 6.
[Table 6]
[0038]
As shown in Table 1, when one kind of inorganic salt is added to the seaweed treatment liquid diluted with seaweed treatment agent, the pH of the seaweed treatment liquid decreases as the amount of inorganic salt added increases. did.
On the other hand, as shown in Tables 2 and 3, when the inorganic salt and the organic acid salt are added in combination, the pH of the treatment liquid does not decrease even when the addition amount of the inorganic salt and the organic acid salt is increased. It showed a constant value.
As shown in Table 4, when two types of inorganic salts were added in combination, the pH of the treatment liquid did not decrease even when the amount of inorganic salts added increased, and showed a substantially constant value.
As shown in Table 5, when the inorganic salts and amino acids were added in combination, the pH of the treatment liquid did not decrease even when the amounts of the inorganic salts and amino acids added increased, indicating a substantially constant value.
As shown in Table 6, when two kinds of inorganic salts and organic acid salt are added in combination, the pH of the treatment liquid does not decrease even if the addition amount of the inorganic salts and organic acid salt increases, and is almost constant. The value of was shown.
[0039]
【The invention's effect】
According to the inventions according to claims 1 to 4 of the present invention, the use of a high salt treatment mixed salt that causes little pH fluctuation of the acid treatment liquid even when the amount added to the acid treatment liquid is increased or decreased, to the human body and the environment. It is possible to provide a high salinity nori treatment solution that can be used in a wide range of pH at low cost without adversely affecting, and can efficiently remove and prevent miscellaneous algae and diseases in a short time. . In addition, there can be provided a processing solution for laver that is less susceptible to pH fluctuations due to the amount of inorganic salts dissolved, can easily determine the acid concentration from the pH of the processing solution, and is less likely to cause uneven effects. According to the invention of claim 5 of the present invention, the acid concentration can be easily grasped from the pH of the treatment liquid, and it is easy to maintain the acid concentration constant during the laver treatment, and the effect is uneven. It is possible to provide a laver treatment method capable of treating laver without generating.
Claims (5)
(a)リンゴ酸、クエン酸、酢酸、乳酸、酒石酸、フマル酸から選ばれる一種又は二種以上の有機酸(A) One or more organic acids selected from malic acid, citric acid, acetic acid, lactic acid, tartaric acid, and fumaric acid
(b)グリシン、アラニン、アスパラギン酸、グルタミン酸から選ばれる一種又は二種以上のアミノ酸、及び/又は該アミノ酸のナトリウム塩、カリウム塩、マグネシウム塩、カルシウム塩から選ばれる一種又は二種以上のアミノ酸塩(B) One or more amino acids selected from glycine, alanine, aspartic acid, and glutamic acid, and / or one or more amino acid salts selected from sodium, potassium, magnesium, and calcium salts of the amino acid
(c)硫酸ナトリウム、硫酸カリウム、硫酸マグネシウム、硫酸アンモニウム、硫酸カルシウム、硫酸鉄、リン酸ナトリウム、リン酸カリウム、リン酸マグネシウム、リン酸アンモニウム、リン酸カルシウム、炭酸ナトリウム、炭酸カリウム、炭酸マグネシウム、炭酸アンモニウム、炭酸カルシウムからなる群から選択される一種以上の第二の無機塩類(C) sodium sulfate, potassium sulfate, magnesium sulfate, ammonium sulfate, calcium sulfate, iron sulfate, sodium phosphate, potassium phosphate, magnesium phosphate, ammonium phosphate, calcium phosphate, sodium carbonate, potassium carbonate, magnesium carbonate, ammonium carbonate, One or more second inorganic salts selected from the group consisting of calcium carbonate
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003196077A JP4435510B2 (en) | 2003-07-11 | 2003-07-11 | High salinity nori treatment liquid and nori treatment method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003196077A JP4435510B2 (en) | 2003-07-11 | 2003-07-11 | High salinity nori treatment liquid and nori treatment method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005027557A JP2005027557A (en) | 2005-02-03 |
| JP4435510B2 true JP4435510B2 (en) | 2010-03-17 |
Family
ID=34206723
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003196077A Expired - Fee Related JP4435510B2 (en) | 2003-07-11 | 2003-07-11 | High salinity nori treatment liquid and nori treatment method |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4435510B2 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4629149B2 (en) * | 2009-03-27 | 2011-02-09 | Jfeミネラル株式会社 | How to recover or prevent discoloration of seaweed |
| JP4750217B2 (en) * | 2009-03-27 | 2011-08-17 | Jfeミネラル株式会社 | How to recover or prevent discoloration of seaweed |
| EP2934131A4 (en) * | 2012-12-18 | 2016-06-22 | Kemin Ind Inc | Compositions for the control of algae in commercial horticulture |
| CN109198583B (en) * | 2018-10-19 | 2022-02-22 | 广州暨南生物医药研究开发基地有限公司 | Seaweed source low sodium salt suitable for hypertension patients and preparation method thereof |
| CN109170804B (en) * | 2018-10-19 | 2022-02-22 | 广州暨南生物医药研究开发基地有限公司 | Microalgae polysaccharide low-sodium salt suitable for hypertension patients and preparation method thereof |
| KR102685489B1 (en) * | 2021-12-31 | 2024-07-15 | 국립군산대학교산학협력단 | Nutrient composition for purple laver using the ionized alkali water and water solule humic acid |
| JP7638015B1 (en) | 2023-09-06 | 2025-03-03 | 株式会社ダイイチ | Seaweed color enhancer |
-
2003
- 2003-07-11 JP JP2003196077A patent/JP4435510B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005027557A (en) | 2005-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4435510B2 (en) | High salinity nori treatment liquid and nori treatment method | |
| JPH01202404A (en) | Wood preservative | |
| JP3296174B2 (en) | Nori treatment method and nori treatment liquid | |
| JP3631466B2 (en) | Cultured laver treatment agent, cultured laver treatment solution, and cultured laver treatment method | |
| KR100690080B1 (en) | Method for improving water quality of tank systems | |
| JP3991381B2 (en) | Nori processing method and nori processing solution | |
| JP4560607B2 (en) | Nori acid treatment agent | |
| JP2525154B2 (en) | Fish egg processing method | |
| JP4633896B2 (en) | Algicidal fungicide | |
| JP3610928B2 (en) | Treatment agent for cultured seaweed and treatment method | |
| JPH11286407A (en) | Diatom control agent | |
| JP2008099648A (en) | Nori processing method and nori work boat | |
| JP3582483B2 (en) | Treatment agent and method for controlling disease and algae of cultured seaweed | |
| EP0599903B1 (en) | Hydrofluoric acid compositions | |
| JP2000256106A (en) | Algicidal fungicide for cultured seaweed and method for treating cultured seaweed using the same | |
| US3948632A (en) | Control of algae, aquatic plants, and the like | |
| JP4695377B2 (en) | Algicide | |
| JP4923215B2 (en) | Nori acid treatment agent | |
| JP4344273B2 (en) | Seaweed treatment method for controlling seaweeds and disease control of seaweed | |
| JP2001086889A (en) | Nori treatment method and nori treatment liquid | |
| JP4409153B2 (en) | How to control miscellaneous algae generated during seaweed cultivation | |
| JP7638015B1 (en) | Seaweed color enhancer | |
| JPH11169000A (en) | Nori cultivation method | |
| JP3609773B2 (en) | Cultured laver treatment agent, cultured laver treatment solution, and cultured laver treatment method | |
| KR970004971B1 (en) | Seaweed Nutrition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050414 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080501 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080624 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090511 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090629 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20091130 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20091224 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 4435510 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130108 Year of fee payment: 3 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140108 Year of fee payment: 4 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| LAPS | Cancellation because of no payment of annual fees |